The largest database of trusted experimental protocols

Stata be version 17

Manufactured by StataCorp
Sourced in United States

STATA/BE version 17.0 is a software package designed for statistical analysis and data management. It provides a comprehensive set of tools for data manipulation, statistical modeling, and visualization. The software is suitable for a wide range of applications, including academic research, business analytics, and policy analysis.

Automatically generated - may contain errors

26 protocols using stata be version 17

1

Replicable AHA Metric Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Data preparation and general analyses were conducted in Stata/BE Version 17.0 (StataCorp LP, College Station, TX). Mplus Version 8.736 was used for factor analyses and GMM, while Bayesian MLIRT modelling was performed using the “sirt” package47 in R 4.1.048 , with RStudio 1.4.171749 . Statistical significance was defined as p ≤ 0.05. The Stata, Mplus, and R syntax to replicate analyses presented in this paper are openly available online at https://github.com/OliviaMalkowski/AHA-metric.git.
+ Open protocol
+ Expand
2

Racial Disparities in CJR Penalties

Check if the same lab product or an alternative is used in the 5 most similar protocols
We obtained CJR performance information from Medicare data1 and hospital characteristics from 2016 to 2019 Impact Files, 2017 inpatient claims, and the 2018 American Hospital Association Survey. Hospitals without data were excluded (15 in 2016, 16 in 2017, 6 in 2018, and 1 in 2019). Hospitals with high Black and Hispanic populations were defined as those in the top quintile of proportion of patients of Black and Hispanic race and ethnicity. Safety-net hospitals were defined as those in the top quintile of Disproportionate Share Hospital index.
Calculating marginal effect sizes from multivariate regressions in Stata/BE version 17.0 between June 6, 2022, and September 23, 2022, we tested associations between caseloads with Black and Hispanic populations and Disproportionate Share Hospital index and the receipt of penalties, controlling for hospital characteristics and case mix. Two-tailed P < .05 was considered statistically significant. The Washington University Human Research Protection Office approved this cross-sectional study, which followed the STROBE reporting guideline. Informed consent was waived due to the deidentified nature of the data.
+ Open protocol
+ Expand
3

Retrospective Dental Treatment Review

Check if the same lab product or an alternative is used in the 5 most similar protocols
This study conducted a retrospective review of dental records for patients who underwent treatment at the Department of Advanced General Dentistry, Faculty of Dentistry, Mahidol University, Bangkok, Thailand between January 2, 2003, and December 30, 2013. The inclusion criteria for the study were patients aged 18 years or older, availability of information in the dental chart record, completion of dental treatment, and at least one recall visit. The sample size for the study was calculated using the power and sample size function of STATA/BE version 17.0 (Stata Corp., TX, USA) program. A sample size of 458 was used to achieve a hazard ratio of 1.3 with 80% power and a type I error probability of 0.05. To account for incomplete dental treatment records, an additional 10% was included, resulting in a final sample size of 500 charts.
+ Open protocol
+ Expand
4

Survival Analysis of PD-1/PD-L1 Blockade Therapy

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cutoff values for sPD-1 and sPD-L1 concentrations were defined as the median for each cancer type, so that survival analysis according to the soluble markers would not be affected by the potential difference in distributions of sPD-1 and sPD-L1 concentrations among cancer types. The outcome of PD-1 blockade therapy was compared between patients with high or low circulating levels of sPD-1 or sPD-L1. Pairwise comparisons of sPD-1 and sPD-L1 levels were also performed. PFS and OS curves were constructed by the Kaplan-Meier method. Between-group differences in survival analyses were assessed with the log-rank test. The hazard ratio (HR) and its 95% confidence interval (CI) were determined with the use of a Cox proportional hazard regression model. Adjustment for possible confounding factors was performed with a multivariable regression model including explanatory variables with a p value of <0.1 in univariable analysis. A two-sided p value of <0.05 was considered statistically significant. All statistical analysis was performed with Stata BE version 17.0 (StataCorp) or GraphPad Prism 9.0 software.
+ Open protocol
+ Expand
5

Cancer Survivors' Smoking and HRQoL

Check if the same lab product or an alternative is used in the 5 most similar protocols
Descriptive statistics, including frequencies and percentages, were used to present the categorical variables, and chi-square tests were employed to examine the differences between the two groups by evaluating the distribution of these variables. A complex survey design was considered by adjusting for stratification and clustering at the primary sampling unit, using sampling weights to compute nationwide representative frequencies and proportions. Multiple imputations were conducted using the predictive mean-matching method to address missing values, with k = 5 imputations.
A logistic regression model was used to calculate the odds of having poor HRQoL among cancer survivors based on their smoking status (never, former, and current smokers), adjusting for multiple potential confounders based on the aforementioned covariates. The predictive probability of poor HRQoL for each smoking exposure group was calculated. Secondary analyses explored the effects of tobacco-related cancers (TRC) and non-TRC on HRQoL, as well as potential interactions between HRQoL, age, and gender. Statistical significance was determined at α < 0.05, with the data analyzed using STATA/BE version 17.0.
+ Open protocol
+ Expand
6

Demographic Factors and Dental Caries Risk

Check if the same lab product or an alternative is used in the 5 most similar protocols
Demographic data were evaluated using descriptive statistics. The relationship between dental caries increments and risk factors for caries was analyzed using the Cox proportional hazard regression model. Hazard ratios (HR) and 95% confidence intervals (95%CI) were calculated for each risk variable. All covariates, including sociodemographic factors, oral health condition, and caries risk level, were considered in the analysis. The software used for analysis was STATA/BE version 17.0 (Stata Corp., TX, USA).
+ Open protocol
+ Expand
7

Assessing Patient and Provider Attitudes Towards Video Visits

Check if the same lab product or an alternative is used in the 5 most similar protocols
Data analyses were conducted using STATA/BE version 17.0. Independent means t-tests and Fisher’s exact test compared intervention group participants to control group participants as well as acceptors to decliners to participate in the study. Free-text responses were summarized and used to provide context for our findings. Patient and provider attitudes were assessed using descriptive statistics. In addition, we used independent t-tests to compare the difference in rating of the patient and provider attitudes with and without device use for video visits. Statistical significance criterion was set at p < 0.05.
+ Open protocol
+ Expand
8

Survival Outcomes in Oncology Patients

Check if the same lab product or an alternative is used in the 5 most similar protocols
Statistical analysis was carried out using STATA BE version 17.0. Basic descriptive statistics were performed with continuous variables displayed as mean values with associated 95% confidence intervals (CIs). Statistical tests performed included Kruskal-Wallis or chi-squared test as appropriate. For the purposes of temporal analysis (i.e. changes over time), patients were grouped into two groups: group 1 diagnosed between 2012 and 2016 and group 2 between 2017 and 2021. Survival outcomes included overall survival (OS) (death from any cause) and disease-free survival (DFS) (either tumour recurrence or death from any cause). The Kaplan-Meier method was used for analysis of survival outcomes with differences between groups estimated using the log-rank test. For the purpose of statistical analysis, a p value of less than 0.05 was considered significant.
+ Open protocol
+ Expand
9

Assessing Patient and Provider Attitudes Towards Video Visits

Check if the same lab product or an alternative is used in the 5 most similar protocols
Data analyses were conducted using STATA/BE version 17.0. Independent means t-tests and Fisher’s exact test compared intervention group participants to control group participants as well as acceptors to decliners to participate in the study. Free-text responses were summarized and used to provide context for our findings. Patient and provider attitudes were assessed using descriptive statistics. In addition, we used independent t-tests to compare the difference in rating of the patient and provider attitudes with and without device use for video visits. Statistical significance criterion was set at p < 0.05.
+ Open protocol
+ Expand
10

Evaluating Logistic Regression Models for ASQ:SE

Check if the same lab product or an alternative is used in the 5 most similar protocols
The five logistic regression models described above were also repeated for an ASQ:SE score categorized as (i) ≥59; and (ii) < 59 (Supplement: Tables 4 and 5). The robustness of the main results to the way of coding the common variables encompassing both parents was also evaluated through complete case analysis, by running logistic regressions with only those children whose parents had all information available on education level and lifestyle (Supplement: Tables 6 and 7).
All analysis were performed using Stata/BE version 17.0 (StataCorp, College Station, Texas 77,845 US).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!